August 1, 2005Expert Review of Anti-infective Therapy
Coxsackievirus-induced myocarditis: new trends in treatment
Population
Children and young adults with Coxsackievirus-induced myocarditis
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Emerging candidates expand the therapeutic pipeline for viral myocarditis; leaves open clinical translation beyond supportive care.
Structured PICO
P
Population
Children and young adults with Coxsackievirus-induced myocarditis
I
Intervention
Novel treatments including virus entry inhibitors (pleconaril, WIN 54954, CAR-Fc), nucleic acid-based antivirals, immunomodulatory agents (interferons, immunoglobulins), enzyme inhibitors, and cellular cardiomyoplasty
This review outlines emerging targeted therapies for Coxsackievirus-induced myocarditis, which may eventually replace or supplement current supportive treatments.
Cite This Study
Liu et al. (2005) studied this question.